Literature DB >> 27329540

Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Kimihiko Oishi1, Ronen Arnon2,3, Melissa P Wasserstein1, George A Diaz1.   

Abstract

LT is an effective therapeutic option for a variety of IEM. This approach can significantly improve the quality of life of patients who suffer from severe disease manifestations and/or life-threatening metabolic decompensations despite medical/dietary management. Due to the significant risks for systemic complications from surgical stressors, careful perioperative management is vital. Even after LT, some disorders require long-term dietary restriction, medical management, and monitoring of metabolites. Successful liver transplant for these complex disorders can be achieved with disease- and patient-specific strategies using a multidisciplinary approach. In this article, we review indications, complications, perioperative management, and long-term follow-up recommendations for IEM that are treatable with LT.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  inborn errors of metabolism; long-term follow-up; pediatric liver transplantation; perioperative management

Mesh:

Year:  2016        PMID: 27329540      PMCID: PMC5142218          DOI: 10.1111/petr.12741

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  144 in total

Review 1.  Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature.

Authors:  B J Alkofer; L Chiche; A Khayat; J P Deshayes; A Lepage; E Saloux; Y Reznik
Journal:  Transplant Proc       Date:  2005-06       Impact factor: 1.066

2.  Liver disorders in children: the indications for liver replacement in parenchymal and metabolic diseases.

Authors:  A P Mowat
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

3.  Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis.

Authors:  E M Sokal; F Van Hoof; D Alberti; J de Ville de Goyet; T de Barsy; J B Otte
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

Review 4.  Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.

Authors:  Daisuke Morioka; Mureo Kasahara; Yasutsugu Takada; Yasumasa Shirouzu; Kaoru Taira; Seisuke Sakamoto; Kenji Uryuhara; Hiroto Egawa; Hiroshi Shimada; Koichi Tanaka
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

5.  Heterozygote to homozygote related living donor liver transplantation in maple syrup urine disease: a case report.

Authors:  N Patel; J Loveland; M Zuckerman; P Moshesh; R Britz; J Botha
Journal:  Pediatr Transplant       Date:  2015-02-10

Review 6.  Anesthetic considerations in patients with mitochondrial defects.

Authors:  Julie Niezgoda; Phil G Morgan
Journal:  Paediatr Anaesth       Date:  2013-03-28       Impact factor: 2.556

7.  Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation.

Authors:  Rolf Schauer; Manfred Stangl; Thomas Lang; Andreas Zimmermann; Alexander Chouker; Alexander L Gerbes; Friedrich W Schildberg; Horst G Rau
Journal:  J Pediatr Surg       Date:  2003-08       Impact factor: 2.545

8.  Perioperative management of a child with glycogen storage disease type III undergoing cardiopulmonary bypass and repair of an atrial septal defect.

Authors:  David Mohart; Pierantonio Russo; Joseph D Tobias
Journal:  Paediatr Anaesth       Date:  2002-09       Impact factor: 2.556

9.  Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2013-06-28       Impact factor: 4.406

Review 10.  Liver transplantation for Wilson's disease.

Authors:  Michael L Schilsky
Journal:  Ann N Y Acad Sci       Date:  2014-05       Impact factor: 5.691

View more
  10 in total

Review 1.  Transplantation as disease modifying therapy in adults with inherited metabolic disorders.

Authors:  Sandra Sirrs; Fady Hannah-Shmouni; Stephen Nantel; James Neuberger; Eric M Yoshida
Journal:  J Inherit Metab Dis       Date:  2018-02-01       Impact factor: 4.982

Review 2.  Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.

Authors:  Nishitha R Pillai; Bridget M Stroup; Anna Poliner; Linda Rossetti; Brandy Rawls; Brian J Shayota; Claudia Soler-Alfonso; Hari Priya Tunuguntala; John Goss; William Craigen; Fernando Scaglia; V Reid Sutton; Ryan Wallace Himes; Lindsay C Burrage
Journal:  Mol Genet Metab       Date:  2019-11-07       Impact factor: 4.797

Review 3.  CDG Therapies: From Bench to Bedside.

Authors:  Sandra Brasil; Carlota Pascoal; Rita Francisco; Dorinda Marques-da-Silva; Giuseppina Andreotti; Paula A Videira; Eva Morava; Jaak Jaeken; Vanessa Dos Reis Ferreira
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

4.  Application of graft-derived cell-free DNA in ornithine transcarbamylase deficiency patient after living donor liver transplantation: Two case reports.

Authors:  Hoi-Ioi Ng; Li-Ying Sun; Zhi-Jun Zhu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

5.  Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patient.

Authors:  Giorgia Olivieri; Diego Martinelli; Daniela Longo; Chiara Grimaldi; Daniela Liccardo; Ivano Di Meo; Andrea Pietrobattista; Anna Sidorina; Michela Semeraro; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2021-05-19       Impact factor: 4.123

Review 6.  Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs.

Authors:  Terry G J Derks; David F Rodriguez-Buritica; Ayesha Ahmad; Foekje de Boer; María L Couce; Sarah C Grünert; Philippe Labrune; Nerea López Maldonado; Carolina Fischinger Moura de Souza; Rebecca Riba-Wolman; Alessandro Rossi; Heather Saavedra; Rupal Naik Gupta; Vassili Valayannopoulos; John Mitchell
Journal:  Nutrients       Date:  2021-10-27       Impact factor: 5.717

Review 7.  Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.

Authors:  Huey-Ling Chen; Shang-Hsin Wu; Shu-Hao Hsu; Bang-Yu Liou; Hui-Ling Chen; Mei-Hwei Chang
Journal:  J Biomed Sci       Date:  2018-10-26       Impact factor: 8.410

8.  Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia.

Authors:  Casey Siegel; Ronen Arnon; Sander Florman; John Bucuvalas; Kimihiko Oishi
Journal:  Nutrients       Date:  2020-09-29       Impact factor: 5.717

9.  Efficacy of Living Donor Liver Transplantation in Patients with Methylmalonic Acidemia.

Authors:  Jae Guk Jang; Seak Hee Oh; Yu Bin Kim; Seo Hee Kim; Han-Wook Yoo; Beom Hee Lee; Jung-Man Namgoong; Dae Yeon Kim; Ki-Hun Kim; Gi-Won Song; Deok-Bog Moon; Shin Hwang; Sung-Gyu Lee; Kyung Mo Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-05-04

10.  Liver transplantation in children with inborn errors of metabolism: 30 years experience in NSW, Australia.

Authors:  Noha Elserafy; Sue Thompson; Troy Dalkeith; Michael Stormon; Gordon Thomas; Albert Shun; Janine Sawyer; Shanti Balasubramanian; Kaustuv Bhattacharya; Nadia Badawi; Carolyn Ellaway
Journal:  JIMD Rep       Date:  2021-05-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.